What's new in haemolytic uraemic syndrome?

European Journal of Pediatrics

Volumn 167, Issue 9, 2008, Pages 965-971

  Johnson, Sally ^a   Taylor, C Mark ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

ADAMTS13; C3; Complement dysregulation; Complement factor H; Factor B; Factor H related proteins; Factor I; Haemolytic uraemic syndrome; Membrane cofactor protein (CD46); Thrombotic thrombocytopenic purpura; Von Willebrand protease

Indexed keywords

MONOCLONAL ANTIBODY;

BACTERIAL INFECTION; COMPLEMENT ALTERNATIVE PATHWAY; DISEASE CLASSIFICATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI; GENE MUTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; LIVER TRANSPLANTATION; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW;

COMPLEMENT PATHWAY, ALTERNATIVE; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS;

EID: 48149105986     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0745-7     Document Type: Review

References (56)

1. JA Ake S Jelacic MA Ciol SL Watkins KF Murray DL Christie EJ Klein PI Tarr 2005 Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion Pediatrics 115 e673 e680
2. N Besbas D Karpman D Landau C Loirat W Proesmans G Remuzzi G Rizzoni CM Taylor N Van de Kar LB Zimmerhackl 2006 A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders Kidney Int 70 423 431
3. M Bielaszewska 2007 Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm PLoS ONE 2 e1024
4. E Bresin E Daina M Noris F Castelletti R Stefanov P Hill TH Goodship G Remuzzi 2006 Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background Clin J Am Soc Nephrol 1 88 99
5. J Caprioli P Bettinaglio PF Zipfel B Amadei E Daina S Gamba C Skerka N Marziliano G Remuzzi M Noris 2001 The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20 J Am Soc Nephrol 12 297 307
6. J Caprioli M Noris S Brioschi G Pianetti F Castelletti P Bettinaglio C Mele E Bresin L Cassis S Gamba F Porrati S Bucchioni G Monteferrante CJ Fang MK Liszewski D Kavanagh JP Atkinson G Remuzzi 2006 Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome Blood 108 1267 1279
7. E Caron VF Crepin N Simpson S Knutton J Garmendia G Frankel 2006 Subversion of actin dynamics by EPEC and EHEC Curr Opin Microbiol 9 40 45
8. HI Cheong BS Lee HG Kang H Hahn KS Suh IS Ha Y Choi 2004 Attempted treatment of factor H deficiency by liver transplantation Pediatr Nephrol 19 454 458
9. S Dieguez S Ayuso M Brindo E Osinde C Canepa 2004 Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome Nephron Clin Pract 97 c118 c122
10. MA Dragon-Durey C Loirat S Cloarec MA Macher J Blouin H Nivet L Weiss WH Fridman V Fremeaux-Bacchi 2005 Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome J Am Soc Nephrol 16 555 563
11. EJ Elliott RM Robins-Browne EV O'Loughlin V Bennett-Wood J Bourke P Henning GG Hogg J Knight H Powell D Redmond 2001 Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features Arch Dis Child 85 125 131
12. J Esparza-Gordillo E Goicoechea de Jorge A Buil L Carreras Berges M Lopez-Trascasa P Sanchez-Corral S Rodriguez de Cordoba 2005 Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 Hum Mol Genet 14 703 712
13. G Frankel AD Phillips I Rosenshine G Dougan JB Kaper S Knutton 1998 Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements Mol Microbiol 30 911 921
14. V Fremeaux-Bacchi N Arzouk S Ferlicot B Charpentier R Snanoudj A Durrbach 2007 Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism Am J Transplant 7 2047 2051
15. Fremeaux-Bacchi VGT, Regnier CH, Dragon-Durey MA, Janssen B, Atkinson J (2007) Mutations in complement C3 predispose to development of atypical haemolytic uraemic syndrome. In: XIth European meeting on complement in human disease. Elsevier, Cardiff, UK
16. Fremeaux-Bacchi V, Kemp EJ, Goodship JA, Dragon-Durey M-A, Strain L, Loirat C, Deng H-W, Goodship THJ (2005) The development of atypical HUS is influenced by susceptibility factors in factor H and membrane cofactor protein-evidence from two independent cohorts. J Med Genet 42(11):852-856
17. AW Friedrich M Bielaszewska WL Zhang M Pulz T Kuczius A Ammon H Karch 2002 Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms J Infect Dis 185 74 84
18. AX Garg RS Suri N Barrowman F Rehman D Matsell MP Rosas-Arellano M Salvadori RB Haynes WF Clark 2003 Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression JAMA 290 1360 1370
19. A Gerber H Karch F Allerberger HM Verweyen LB Zimmerhackl 2002 Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study J Infect Dis 186 493 500
20. S Heinen M Jozsi A Hartmann M Noris G Remuzzi C Skerka PF Zipfel 2007 Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells J Am Soc Nephrol 18 506 514
21. H Jalanko S Peltonen A Koskinen J Puntila H Isoniemi C Holmberg A Pinomaki E Armstrong A Koivusalo E Tukiainen H Makisalo J Saland G Remuzzi S de Cordoba R Lassila S Meri TS Jokiranta 2008 Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H Am J Transplant 8 216 221
22. TS Jokiranta ZZ Cheng H Seeberger M Jozsi S Heinen M Noris G Remuzzi R Ormsby DL Gordon S Meri J Hellwage PF Zipfel 2005 Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site Am J Pathol 167 1173 1181
23. M Jozsi S Heinen A Hartmann CW Ostrowicz S Halbich H Richter A Kunert C Licht RE Saunders SJ Perkins PF Zipfel C Skerka 2006 Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions J Am Soc Nephrol 17 170 177
24. M Jozsi C Licht S Strobel SLH Zipfel H Richter S Heinen PF Zipfel C Skerka 2008 Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency Blood 111 1512 1514
25. H Karch NA Strockbine AD O'Brien 1986 Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay FEMS Microbiol Lett 35 141 145
26. MA Karmali 1989 Infection by verocytotoxin-producing Escherichia coli Clin Microbiol Rev 2 15 38
27. D Kavanagh A Richards V Fremeaux-Bacchi M Noris T Goodship G Remuzzi JP Atkinson 2007 Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome Clin J Am Soc Nephrol 2 591 596
28. D Kavanagh A Richards M Noris R Hauhart MK Liszewski D Karpman JA Goodship V Fremeaux-Bacchi G Remuzzi TH Goodship JP Atkinson 2008 Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome Mol Immunol 45 95 105
29. H Kleanthous HR Smith SM Scotland RJ Gross B Rowe CM Taylor DV Milford 1990 Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects Arch Dis Child 65 722 727
30. K Ludwig MA Karmali V Sarkim C Bobrowski M Petric H Karch DE Muller-Wiefel 2001 Antibody response to shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome J Clin Microbiol 39 2272 2279
31. RM Lynn SJ O'Brien CM Taylor GK Adak H Chart T Cheasty JE Coia IA Gillespie ME Locking WJ Reilly HR Smith A Waters GA Willshaw 2005 Childhood hemolytic uremic syndrome, United Kingdom and Ireland Emerg Infect Dis 11 590 596
32. NE Moghal MA Ferreira AJ Howie DV Milford E Raafat CM Taylor 1998 The late histologic findings in diarrhea-associated hemolytic uremic syndrome J Pediatr 133 220 223
33. J Mukherjee K Chios D Fishwild D Hudson S O'Donnell SM Rich A Donohue-Rolfe S Tzipori 2002 Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection Infect Immun 70 612 619
34. M Nangaku CE Alpers J Pippin SJ Shankland K Kurokawa S Adler RJ Johnson WG Couser 1997 Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9 Kidney Int 52 1570 1578
35. HP Neumann M Salzmann B Bohnert-Iwan T Mannuelian C Skerka D Lenk BU Bender M Cybulla P Riegler A Konigsrainer U Neyer A Bock U Widmer DA Male G Franke PF Zipfel 2003 Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries J Med Genet 40 676 681
36. M Noris S Brioschi J Caprioli M Todeschini E Bresin F Porrati S Gamba G Remuzzi 2003 Familial haemolytic uraemic syndrome and an MCP mutation Lancet 362 1542 1547
37. M Ohali H Shalev M Schlesinger Y Katz L Kachko R Carmi S Sofer D Landau 1998 Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H Pediatr Nephrol 12 619 624
38. D Orth R Wurzner 2006 What makes an enterohemorrhagic Escherichia coli? Clin Infect Dis 43 1168 1169
39. D Perez-Caballero C Gonzalez-Rubio ME Gallardo M Vera M Lopez-Trascasa S Rodriguez de Cordoba P Sanchez-Corral 2001 Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome Am J Hum Genet 68 478 484
40. N Pradel V Livrelli C De Champs J-B Palcoux A Reynaud F Scheutz J Sirot B Joly C Forestier 2000 Prevalence and characterization of shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France J Clin Microbiol 38 1023 1031
41. G Remuzzi P Ruggenenti D Codazzi M Noris J Caprioli G Locatelli B Gridelli 2002 Combined kidney and liver transplantation for familial haemolytic uraemic syndrome Lancet 359 1671 1672
42. G Remuzzi P Ruggenenti M Colledan B Gridelli A Bertani P Bettinaglio S Bucchioni A Sonzogni E Bonanomi V Sonzogni JL Platt N Perico M Noris 2005 Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation Am J Transplant 5 1146 1150
43. A Richards MR Buddles RL Donne BS Kaplan E Kirk MC Venning CL Tielemans JA Goodship TH Goodship 2001 Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition Am J Hum Genet 68 485 490
44. A Richards EJ Kemp MK Liszewski JA Goodship AK Lampe R Decorte MH Muslumanogglu S Kavukcu G Filler Y Pirson LS Wen JP Atkinson THJ Goodship 2003 Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome PNAS 100 12966 12971
45. N Safdar A Said RE Gangnon DG Maki 2002 Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis JAMA 288 996 1001
46. JM Saland SH Emre BL Shneider C Benchimol S Ames JS Bromberg G Remuzzi L Strain TH Goodship 2006 Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation Am J Transplant 6 1948 1952
47. P Sanchez-Corral C Gonzalez-Rubio S Rodriguez de Cordoba M Lopez-Trascasa 2004 Functional analysis in serum from atypical hemolytic uremic syndrome patients reveals impaired protection of host cells associated with mutations in factor H Mol Immunol 41 81 84
48. P Sanchez-Corral D Perez-Caballero O Huarte AM Simckes E Goicoechea M Lopez-Trascasa SR de Cordoba 2002 Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome Am J Hum Genet 71 1285 1295
49. RE Saunders TH Goodship PF Zipfel SJ Perkins 2006 An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations Hum Mutat 27 21 30
50. AL Sellier-Leclerc V Fremeaux-Bacchi MA Dragon-Durey MA Macher P Niaudet G Guest B Boudailliez F Bouissou G Deschenes S Gie M Tsimaratos M Fischbach D Morin H Nivet C Alberti C Loirat 2007 Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome J Am Soc Nephrol 18 2392 2400
51. AS Sheoran S Chapman P Singh A Donohue-Rolfe S Tzipori 2003 Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants Infect Immun 71 3125 3130
52. H Trachtman A Cnaan E Christen K Gibbs S Zhao DWK Acheson R Weiss FJ Kaskel A Spitzer GH Hirschman 2003 Effect of an oral shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial JAMA 290 1337 1344
53. A Veyradier B Obert E Haddad S Cloarec H Nivet M Foulard F Lesure P Delattre M Lakhdari D Meyer J-P Girma C Loriat 2003 Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome J Pediatr 142 310 317
54. P Warwicker TH Goodship RL Donne Y Pirson A Nicholls RM Ward P Turnpenny JA Goodship 1998 Genetic studies into inherited and sporadic hemolytic uremic syndrome Kidney Int 53 836 844
55. AM Waters L Kerecuk D Luk MR Haq MM Fitzpatrick RD Gilbert C Inward C Jones B Pichon C Reid MPE Slack W Van't Hoff MJ Dillon CM Taylor K Tullus 2007 Hemolytic uremic syndrome associated with invasive pneumococcal disease: The United Kingdom experience J Pediatr 151 140 144
56. D Werber SC Behnke A Fruth R Merle S Menzler S Glaser L Kreienbrock R Prager H Tschape P Roggentin J Bockemuhl A Ammon 2007 Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups Am J Epidemiol 165 425 434